CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-17 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −500 | $200.00 | $100K | 4,500 |
| 2024-09-03 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −2,032 | $188.16 | $382K | 3,524 |
| 2024-09-03 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −275 | $188.97 | $52K | 3,249 |
| 2024-09-03 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −2,275 | $190.29 | $433K | 974 |
| 2024-09-03 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −700 | $191.20 | $134K | 274 |
| 2024-09-03 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −274 | $192.04 | $53K | 0 |
| 2024-09-03 | Ball Titus B. Principal Accounting Officer | Sale | −137 | $189.94 | $26K | 0 |
| 2024-08-12 | Wang Xiaodong Director | Gift | −301,457 | 5,266,973 | ||
| 2024-08-09 | Rosenberg Aaron Chief Financial Officer | Grant or award | +118,547 | 118,547 | ||
| 2024-08-09 | Rosenberg Aaron Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +220,987 | 220,987 | ||
| 2024-07-30 | Lee Chan Henry SVP, General Counsel | Sale | −834 | $160.57 | $134K | 0 |
| 2024-07-01 | Wang Julia Aijun Chief Financial Officer | Sale | −472 | $143.90 | $68K | 0 |
| 2024-06-24 | Wang Julia Aijun Chief Financial Officer | Sale | −899 | $155.66 | $140K | 0 |
| 2024-06-24 | Wang Lai Global Head of R&D | Sale | −1,062 | $159.80 | $170K | 2 |
| 2024-06-24 | Wang Lai Global Head of R&D | Sale | −2 | $161.10 | $322 | 0 |
| 2024-06-24 | Wu Xiaobin President, COO & GM China | Sale | −1,036 | $159.53 | $165K | 423 |
| 2024-06-24 | Wu Xiaobin President, COO & GM China | Sale | −400 | $160.38 | $64K | 23 |
| 2024-06-24 | Wu Xiaobin President, COO & GM China | Sale | −23 | $161.27 | $4K | 0 |
| 2024-06-24 | OYLER JOHN Chief Executive Officer | Sale | −2,389 | $159.49 | $381K | 400 |
| 2024-06-24 | OYLER JOHN Chief Executive Officer | Sale | −400 | $160.12 | $64K | 0 |
Page 37 of 71 · 1,406 trades